Trial Information

Summary: Mount Sinai Medical Center is recruiting subjects with chronic myeloid leukemia who are in blast crisis, accelerated phase, or chronic phase to participate in a clinical study to determine the safety of an experimental drug.

You may be eligible to participate in this study if you:

• Are Male or female at least 18 years of age
• Have chronic myeloid leukemia
• Are resistant or intolerant to Imatinib (Standard treatment for this type of leukemia)

You may not participate in this study if you:

• Have cancer that has spread to your central nervous system
• Have heart disease or impaired heart function
• Have acute liver or kidney disease unrelated to your tumor
• Have participated in another research study within the last 4 weeks
• Are pregnant or breastfeeding
• Have any other clinically significant illnesses
• Already know you are HIV positive. (HIV testing is not mandatory for this study)
• Are currently receiving certain other treatments for your condition. The study doctor will determine if you are eligible.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:02 AM